Cargando…

Identification of Inhibitors of the Leishmania cdc2-Related Protein Kinase CRK3

New drugs are urgently needed for the treatment of tropical parasitic diseases such as leishmaniasis and human African trypanosomiasis (HAT). This work involved a high-throughput screen of a focussed kinase set of ∼3400 compounds to identify potent and parasite-selective inhibitors of an enzymatic L...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cleghorn, Laura A T, Woodland, Andrew, Collie, Iain T, Torrie, Leah S, Norcross, Neil, Luksch, Torsten, Mpamhanga, Chido, Walker, Roderick G, Mottram, Jeremy C, Brenk, Ruth, Frearson, Julie A, Gilbert, Ian H, Wyatt, Paul G
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	WILEY-VCH Verlag 2011
Materias:	Full Papers
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3272345/ https://www.ncbi.nlm.nih.gov/pubmed/21913331 http://dx.doi.org/10.1002/cmdc.201100344

Ejemplares similares

From On-Target to Off-Target Activity: Identification and Optimisation of Trypanosoma brucei GSK3 Inhibitors and Their Characterisation as Anti-Trypanosoma brucei Drug Discovery Lead Molecules
por: Woodland, Andrew, et al.
Publicado: (2013)

IspE Inhibitors Identified by a Combination of In Silico and In Vitro High-Throughput Screening
por: Tidten-Luksch, Naomi, et al.
Publicado: (2012)

Design and Synthesis of Brain Penetrant Trypanocidal N-Myristoyltransferase Inhibitors
por: Bayliss, Tracy, et al.
Publicado: (2017)

The Design and Synthesis of Potent and Selective Inhibitors of Trypanosoma brucei Glycogen Synthase Kinase 3 for the Treatment of Human African Trypanosomiasis
por: Urich, Robert, et al.
Publicado: (2014)

High Throughput Screens Yield Small Molecule Inhibitors of Leishmania CRK3:CYC6 Cyclin-Dependent Kinase
por: Walker, Roderick G., et al.
Publicado: (2011)

Development of Small-Molecule Trypanosoma brucei N-Myristoyltransferase Inhibitors: Discovery and Optimisation of a Novel Binding Mode
por: Spinks, Daniel, et al.
Publicado: (2015)

Optimisation of the Anti-Trypanosoma brucei Activity of the Opioid Agonist U50488
por: Smith, Victoria C, et al.
Publicado: (2011)

Design, Synthesis and Biological Evaluation of Novel Inhibitors of Trypanosoma brucei Pteridine Reductase 1
por: Spinks, Daniel, et al.
Publicado: (2011)

One Scaffold, Three Binding Modes: Novel and Selective Pteridine Reductase 1 Inhibitors Derived from Fragment Hits Discovered by Virtual Screening
por: Mpamhanga, Chidochangu P., et al.
Publicado: (2009)

Discovery of a Novel Class of Orally Active Trypanocidal N-Myristoyltransferase Inhibitors
por: Brand, Stephen, et al.
Publicado: (2011)

High-throughput screening with the Eimeria tenella CDC2-related kinase2/cyclin complex EtCRK2/EtCYC3a
por: Fernández, María L. Suárez, et al.
Publicado: (2012)

A Molecular Hybridization Approach for the Design of Potent, Highly Selective, and Brain-Penetrant N-Myristoyltransferase Inhibitors
por: Harrison, Justin R., et al.
Publicado: (2018)

Screening a protein kinase inhibitor library against Plasmodium falciparum
por: Hallyburton, Irene, et al.
Publicado: (2017)

Crk and CrkL as Therapeutic Targets for Cancer Treatment
por: Park, Taeju
Publicado: (2021)

HTS and hit finding in academia – from chemical genomics to drug discovery
por: Frearson, Julie A., et al.
Publicado: (2009)

Capability of the viral NS1 proteins to bind to the cellular adaptor proteins Crk and CrkL determines sensitivity of influenza viruses to Crk/CrkL expression
por: Hrincius, ER, et al.
Publicado: (2009)

Discovery of Inhibitors of Trypanosoma brucei by Phenotypic Screening of a Focused Protein Kinase Library
por: Woodland, Andrew, et al.
Publicado: (2015)

A Molecular Modeling Approach to Identify Potential Antileishmanial Compounds Against the Cell Division Cycle (cdc)-2-Related Kinase 12 (CRK12) Receptor of Leishmania donovani
por: Broni, Emmanuel, et al.
Publicado: (2021)

Crk and CrkL adaptor proteins: networks for physiological and pathological signaling
por: Birge, Raymond B, et al.
Publicado: (2009)

Domain organization differences explain Bcr-Abl’s preference for CrkL over CrkII
por: Jankowski, Wojciech, et al.
Publicado: (2012)

Crk gets hijacked
por: Van Epps, Heather L.
Publicado: (2005)

Cracking Cancer with CRK
por: Uthamacumaran, Abicumaran, et al.
Publicado: (2009)

Protein turnover and differentiation in Leishmania
por: Besteiro, Sébastien, et al.
Publicado: (2007)

Design, Synthesis and Biological Evaluation of Trypanosoma brucei Trypanothione Synthetase Inhibitors
por: Spinks, Daniel, et al.
Publicado: (2012)

Lessons Learnt from Assembling Screening Libraries for Drug Discovery for Neglected Diseases
por: Brenk, Ruth, et al.
Publicado: (2008)

N-Myristoyltransferase inhibitors as new leads to treat sleeping sickness
por: Frearson, Julie A., et al.
Publicado: (2010)

Discovery of Indoline-2-carboxamide Derivatives as a New Class of Brain-Penetrant Inhibitors of Trypanosoma brucei
por: Cleghorn, Laura A. T., et al.
Publicado: (2015)

Lead Optimization of a Pyrazole Sulfonamide Series of Trypanosoma bruceiN-Myristoyltransferase Inhibitors: Identification and Evaluation of CNS Penetrant Compounds as Potential Treatments for Stage 2 Human African Trypanosomiasis
por: Brand, Stephen, et al.
Publicado: (2014)

Chemical Validation of Trypanothione Synthetase: A POTENTIAL DRUG TARGET FOR HUMAN TRYPANOSOMIASIS
por: Torrie, Leah S., et al.
Publicado: (2009)

Proteins that bind the Src homology 3 domain of CrkI have distinct roles in Crk transformation
por: Zheng, Ji, et al.
Publicado: (2010)

Conditional gene deletion with DiCre demonstrates an essential role for CRK3 in L eishmania mexicana cell cycle regulation
por: Duncan, Samuel M., et al.
Publicado: (2016)

Quantitative assessment of glioblastoma phenotypes in vitro establishes cell migration as a robust readout of Crk and CrkL activity
por: Park, Taeju, et al.
Publicado: (2021)

Distinct Roles in Autophagy and Importance in Infectivity of the Two ATG4 Cysteine Peptidases of Leishmania major
por: Williams, Roderick A. M., et al.
Publicado: (2013)

Development of a 2,4-Diaminothiazole Series for the Treatment of Human African Trypanosomiasis Highlights the Importance of Static–Cidal Screening of Analogues
por: Cleghorn, Laura A. T., et al.
Publicado: (2023)

Crk1/2 and CrkL form a hetero-oligomer and functionally complement each other during podocyte morphogenesis
por: George, Britta, et al.
Publicado: (2014)

Quinol derivatives as potential trypanocidal agents
por: Capes, Amy, et al.
Publicado: (2012)

Genome-Wide Identification and Functional Analyses of the CRK Gene Family in Cotton Reveals GbCRK18 Confers Verticillium Wilt Resistance in Gossypium barbadense
por: Li, Ting-Gang, et al.
Publicado: (2018)

Polymorphisms in the CRK gene and their association with breast cancer risk
por: Wagner, K, et al.
Publicado: (2005)

The Role of Crk Adaptor Proteins in T-Cell Adhesion and Migration
por: Braiman, Alex, et al.
Publicado: (2015)

Bifunctional Role of CrkL during Bone Remodeling
por: Kim, Jung Ha, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_05n5dhd9fs201l84iigdrag2mq